Skip to main content
WHANIN PHARM CO.,LTD logo

WHANIN PHARM CO.,LTD — Investor Relations & Filings

Ticker · 016580 ISIN · KR7016580003 KO Manufacturing
Open in API
Filings indexed 179 across all filing types
Latest filing 2021-03-19 Board/Management Inform…
Country KR South Korea
Listing KO 016580

About WHANIN PHARM CO.,LTD

https://www.whanin.com/?lang=eng

WHANIN PHARM CO.,LTD. is a pharmaceutical company that develops, manufactures, and sells a range of therapeutic products. The company specializes in medications for the Central Nervous System (CNS), with a particular focus on neuropsychiatric treatments such as anti-psychotics and CNS stimulants. In addition to its core CNS portfolio, Whanin Pharm's product line includes pharmaceuticals for the cardiovascular and gastrointestinal systems, antibiotics, and vitamin supplements. The company also provides development and manufacturing services for finished drug formulations.

Recent filings

Filing Released Lang Actions
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details changes to the board of directors, specifically the appointment of an outside director. This falls under the category of Board/Management Information (MANG), which covers announcements regarding changes in the board of directors or senior management.
2021-03-19 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from Hwanin Pharmaceutical titled 'Audit Report Submission' (감사보고서 제출). It provides the audit opinion (unqualified/appropriate), key financial data (assets, liabilities, revenue, profit), and details regarding the external auditor. While it contains financial data, it is a formal notification of the submission of the audit report to the regulatory body (KRX), rather than the full annual report itself. According to the 'Menu vs Meal' rule, this is a report publication announcement/regulatory filing. FY 2020
2021-03-11 Korean
사업보고서 (2020.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for Whan In Pharm Co., Ltd. for the fiscal year 2020 (2020.01.01-2020.12.31). It contains comprehensive financial statements, management discussion and analysis, governance information, and operational details. In the context of Korean corporate filings (DART system), this is the equivalent of an Annual Report (10-K). FY 2020
2021-03-11 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Whanin Pharmaceutical Co., Ltd. It contains the agenda for the 39th Annual General Meeting, including the approval of financial statements, election of directors, and dividend proposals. It also includes detailed financial data (balance sheets, income statements) and governance information (board activities, remuneration) as required by Korean commercial law for shareholder meeting materials. This document is a formal proxy statement/information circular sent to shareholders to solicit votes and provide necessary information for the upcoming meeting.
2021-03-02 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Hwanin Pharmaceutical. It details the date, location, and agenda items (such as financial statement approval, director appointments, and remuneration limits). This type of document is a standard proxy solicitation and information statement provided to shareholders to inform them of upcoming meeting details and agenda items, which falls under the PSI category.
2021-02-22 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Hwanin Pharmaceutical regarding the decision to pay a cash dividend. It specifies the dividend amount per share, the total dividend amount, the dividend record date, and the date of the board resolution. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2021-02-22 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.